Mumbai, 1st December 2025 : DiagnoSearch Life Sciences, one of India’s most trusted and
experienced Clinical Research Organizations (CROs), marks a significant
milestone as it completes 30 years of advancing scientific and clinical
research. To commemorate this landmark anniversary, the organization hosted a
celebratory event at its Mumbai headquarters, inviting select alumni,
long-standing collaborators, and employees who have been integral to its
journey.
Since its inception in 1995, DiagnoSearch has grown
from a central laboratory services provider into a globally respected CRO known
for its scientific rigor, operational excellence, and unwavering commitment to
compliance across clinical operations, data management and biostatistics,
medical affairs and safety management, and quality assurance.
Over the past three decades, DiagnoSearch has
partnered with leading pharmaceutical, biotechnology, and medical device
innovators, supporting hundreds of clinical studies across a wide range of
therapeutic areas. Its work has contributed meaningfully to accelerating drug
development, strengthening clinical evidence, and improving patient outcomes
worldwide.
Today, the organization’s clinical research
capabilities are rated among the best in the country, enabling end-to-end
services across the clinical development lifecycle. DiagnoSearch has delivered
high-quality scientific data that has supported approvals across India, Africa,
the Asia-Pacific region, and other key markets, earning a distinguished
reputation for ethical research, data integrity, and rigorous regulatory
adherence.
The 30-year anniversary was an opportunity for
DiagnoSearch to celebrate its journey and its culture of integrity, teamwork,
and excellence. Its leadership team reflected on the company’s scientific
achievements and its continued commitment to innovation-led clinical research.
Reflecting on the milestone, Dr. Manisha
Ginde, Co-Founder, President & Managing Director, DiagnoSearch Life
Sciences, said, “Completing 30 years is a meaningful milestone for
us, shaped by scientific rigor, the trust of our sponsors, and the steadfast
commitment of our teams. Every step was an opportunity to learn, and the
hurdles and challenges gave us an opportunity to better ourselves and come out
stronger. For DiagnoSearch the journey continues, and as we look ahead, we
remain committed to advancing high-quality research that helps bring safe and
effective therapies to patients around the world.”
Echoing her thoughts, Dr. Vinod Mattoo,
Executive Director, DiagnoSearch Life Sciences, said, “As we
celebrate 30 years of DiagnoSearch, we are excited to look to the future and
remain committed to scaling globally, strengthening our therapeutic depth, and
harnessing advanced technologies to redefine how clinical research is
delivered. The future of DiagnoSearch is one of ambition, innovation, and
lasting impact.”
About DiagnoSearch Life Sciences:
Founded on 29th November 1995, DiagnoSearch Life
Sciences (DiagnoSearch) Pvt. Ltd. is a premium full-service Clinical Research
Organization (CRO) with a 30-year legacy in delivering agile, data-driven
clinical research solutions worldwide. Combining the reach of a global CRO with
the agility of a specialized partner, DLS is trusted by sponsors for its
therapeutic depth, scientific excellence, quality and commitment. The company
provides end-to-end services across the clinical development lifecycle,
including Clinical Operations, Central Laboratory Services, Medical Affairs
& Safety Management, Data Management, Biostatistics, and Scientific &
Regulatory Writing. Under the visionary leadership of Co-Founder, President
& Managing Director, Dr. Manisha Ginde, and late Founder Dr. Vasudeo Ginde,
DiagnoSearch combines scientific rigor with entrepreneurial agility and is
driven by its values of people and integrity. Today, its growing global
presence is spread across South Korea, Mexico, Thailand, Malaysia, Philippines,
Taiwan, and several regions of APAC and Africa. DiagnoSearch continues to
expand its capabilities, adopt advanced technologies, and advance clinical research
to positively impact health outcomes worldwide.
